In utero valproate exposure and autism: long suspected, finally proven.
作者信息
Harden Cynthia L
出版信息
Epilepsy Curr. 2013 Nov;13(6):282-4. doi: 10.5698/1535-7597-13.6.282.
Abstract
摘要
相似文献
1
In utero valproate exposure and autism: long suspected, finally proven.
Epilepsy Curr. 2013 Nov;13(6):282-4. doi: 10.5698/1535-7597-13.6.282.
2
Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
JAMA. 2013 Apr 24;309(16):1696-703. doi: 10.1001/jama.2013.2270.
3
In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring.
J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1324-1331. doi: 10.1136/jnnp-2018-318386. Epub 2018 Aug 3.
4
In utero antiepileptic drug exposure: fetal death and malformations.
Neurology. 2006 Aug 8;67(3):407-12. doi: 10.1212/01.wnl.0000227919.81208.b2.
5
Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect.
CNS Drugs. 2008;22(4):325-34. doi: 10.2165/00023210-200822040-00004.
6
Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?
CNS Drugs. 2020 Feb;34(2):163-169. doi: 10.1007/s40263-019-00694-4.
7
Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy.
Epilepsia. 2015 Jul;56(7):1047-55. doi: 10.1111/epi.13007. Epub 2015 May 11.
8
Sensory and motor characterization in the postnatal valproate rat model of autism.
Dev Neurosci. 2012;34(2-3):258-67. doi: 10.1159/000336646. Epub 2012 May 24.
9
Region-Specific Reduction of BDNF Protein and Transcripts in the Hippocampus of Juvenile Rats Prenatally Treated With Sodium Valproate.
Front Mol Neurosci. 2019 Nov 7;12:261. doi: 10.3389/fnmol.2019.00261. eCollection 2019.
10
Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome.
Dis Model Mech. 2014 Jan;7(1):107-17. doi: 10.1242/dmm.013219. Epub 2013 Oct 17.
引用本文的文献
1
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder.
Curr Neuropharmacol. 2024;22(2):260-289. doi: 10.2174/1570159X22666231003121513.
2
[Sodium valprovate suppresses autophagy in SH-SY5Y cells activating miR-34c-5p/ATG4B signaling pathway].
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1415-1420. doi: 10.12122/j.issn.1673-4254.2018.12.03.
3
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.
J Neuroinflammation. 2017 Sep 4;14(1):179. doi: 10.1186/s12974-017-0938-y.
4
Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders.
BMC Genomics. 2016 Jun 29;17 Suppl 3(Suppl 3):435. doi: 10.1186/s12864-016-2784-1.
5
Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers.
Biochem Biophys Res Commun. 2016 May 27;474(2):291-295. doi: 10.1016/j.bbrc.2016.04.088. Epub 2016 Apr 20.
6
Psychoactive pharmaceuticals as environmental contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-protein interaction network.
BMC Bioinformatics. 2015;16 Suppl 7(Suppl 7):S3. doi: 10.1186/1471-2105-16-S7-S3. Epub 2015 Apr 23.
本文引用的文献
1
Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
JAMA. 2013 Apr 24;309(16):1696-703. doi: 10.1001/jama.2013.2270.
2
In utero exposure to valproic acid and autism--a current review of clinical and animal studies.
Neurotoxicol Teratol. 2013 Mar-Apr;36:47-56. doi: 10.1016/j.ntt.2013.01.004. Epub 2013 Feb 8.
3
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.
J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637-43. doi: 10.1136/jnnp-2012-304270. Epub 2013 Jan 31.
4
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23.
5
Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years.
Epilepsy Behav. 2011 Oct;22(2):240-6. doi: 10.1016/j.yebeh.2011.06.014. Epub 2011 Jul 23.
6
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5.
7
Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes [RETIRED]: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Neurology. 2009 Jul 14;73(2):133-41. doi: 10.1212/WNL.0b013e3181a6b312. Epub 2009 Apr 27.
8
Autism spectrum disorders following in utero exposure to antiepileptic drugs.
Neurology. 2008 Dec 2;71(23):1923-4. doi: 10.1212/01.wnl.0000339399.64213.1a.
9
Neuropsychological effects of exposure to anticonvulsant medication in utero.
Neurology. 2005 Mar 22;64(6):949-54. doi: 10.1212/01.WNL.0000154514.82948.69.
10
The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs.
J Pediatr. 2005 Jan;146(1):118-22. doi: 10.1016/j.jpeds.2004.08.048.
Zotero 插件